Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.

BACKGROUND Rotavirus and HIV infection are major causes of death among children in sub-Saharan Africa. A previous study reported no association between concomitant HIV infection and rotavirus disease severity among hospitalised children in Malawi. This study examined rotavirus antigenaemia and broader immune responses among HIV-infected and uninfected children. METHODS Stored (-80°C), paired sera from acute and convalescent phases of Malawian children less than 5 years old, hospitalised for acute gastroenteritis in the primary study, collected from July 1997 to June 1999, were utilised. Among children older than 15 months, HIV infection was defined as the presence of HIV antibody in the blood, when confirmed by at least 2 established methods. For those younger than 15 months, nested polymerase chain reaction (PCR) amplification of proviral DNA was used for verification. All were followed for up to 4 weeks after hospital discharge. Rotavirus antigen levels in sera were measured with Premier™ Rotaclone® rotavirus enzyme immunoassay (EIA) kit. Acute-phase sera were examined for 17 cytokines, using Luminex fluorescent bead human cytokine immunoassay kit. Rotavirus-specific IgA and neutralising activity were determined by EIA and microneutralisation (MN) assay, respectively. Human strains and bovine-human reassortants were propagated in MA104 cells with serum-free Iscove's Modified Dulbecco's Medium (IMDM). Differences in results, from specimens with and without HIV infection, were analysed for statistical significance using the chi-square test. RESULTS We detected rotavirus antigen in 30% of the HIV-infected and 21% HIV-uninfected, in the acute-phase sera. HIV-infected children developed slightly prolonged rotavirus antigenaemia compared to HIV-uninfected children. CONCLUSIONS Rotavirus-specific IgA seroconversion rates and neutralising titres were similar in HIV-infected and HIV-uninfected children, thus, HIV infection had no major effect on immune responses to rotavirus infection.

[1]  T. Vesikari,et al.  Rotavirus Antigenemia in Children is Associated With More Severe Clinical Manifestations of Acute Gastroenteritis , 2014, The Pediatric infectious disease journal.

[2]  Stephanie A. Jones,et al.  Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. , 2014, Bulletin of the World Health Organization.

[3]  R. Glass,et al.  Inhibitory Effect of Breast Milk on Infectivity of Live Oral Rotavirus Vaccines , 2010, The Pediatric infectious disease journal.

[4]  S. Madhi,et al.  A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. , 2009, The Journal of infectious diseases.

[5]  A. Steele,et al.  Rotavirus infections among HIV-infected children in Nairobi, Kenya. , 2009, Journal of tropical pediatrics.

[6]  R. Grais,et al.  Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. , 2009, The Lancet. Infectious diseases.

[7]  Manish M Patel,et al.  Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. , 2009, JAMA.

[8]  T. Yoshikawa,et al.  Analysis of Rotavirus Antigenemia and Extraintestinal Manifestations in Children With Rotavirus Gastroenteritis , 2008, Pediatrics.

[9]  P. Dennehy,et al.  Rotavirus Vaccines: an Overview , 2008, Clinical Microbiology Reviews.

[10]  S. Blutt,et al.  Rotavirus : to the gut and beyon d ! , 2006 .

[11]  E. Chiappini,et al.  Viremia and clinical manifestations in children with rotavirus infection. , 2006, The Journal of infectious diseases.

[12]  R. Glass,et al.  Rotavirus antigenemia in patients with acute gastroenteritis. , 2005, The Journal of infectious diseases.

[13]  R. Holman,et al.  Cytokines as Mediators for or Effectors against Rotavirus Disease in Children , 2003, Clinical Diagnostic Laboratory Immunology.

[14]  M. Molyneux,et al.  Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children , 2001, The Lancet.

[15]  K. Kedzierska,et al.  Cytokines and HIV-1: Interactions and Clinical Implications , 2001, Antiviral chemistry & chemotherapy.

[16]  M. Molyneux,et al.  Rotavirus Strain Diversity in Blantyre, Malawi, from 1997 to 1999 , 2001, Journal of Clinical Microbiology.

[17]  C. Dinarello Impact of Basic Research On Tomorrow's MedicineProinflammatory Cytokines , 2000 .

[18]  M. Albert,et al.  Immune Response of Children Who Develop Persistent Diarrhea following Rotavirus Infection , 1999, Clinical Diagnostic Laboratory Immunology.

[19]  G. Karupiah,et al.  Cytokines and immunity to viral infections , 1997, Immunological reviews.

[20]  J. Stockman,et al.  Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine , 2007 .

[21]  Releve Epidemiologique Hebdomadaire Weekly epidemiological record Relevé épidémiologique hebdomadaire Understanding the behavioural and social drivers of vaccine uptake Comprendre les facteurs comportementaux et sociaux de l’adoption des vaccins Note de synthèse de l’OMS – , 2003 .